Myocarditis following mRNA COVID‐19 vaccination: call for endomyocardial biopsy
Abstract Acute myocarditis following mRNA COVID‐19 vaccination was reported by the European Medicine Agency safety committee as a rare adverse event. We present a case series of three young male patients with suspected acute myocarditis following BNT162b2 mRNA COVID‐19 vaccination including results...
Saved in:
Main Authors: | Daniel Kiblboeck, Karin Klingel, Martin Genger, Selina Traxler, Nathalie Braunsteiner, Clemens Steinwender, Joerg Kellermair |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13791 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reviewing the current diagnostic and treatment approaches for myocarditis – analysis of literature
by: Damian Zys, et al.
Published: (2025-01-01) -
Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy
by: Warmusz Oliwia, et al.
Published: (2025-02-01) -
A Case of Right Ventricular Endomyocardial Fibrosis Presenting with Right Ventricular Failure in an Immunocompromised Patient
by: Ratul Ghosh, et al.
Published: (2024-10-01) -
Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits
by: Mizuki Ida, et al.
Published: (2022-06-01) -
Dilated cardiomyopathy and myocarditis: a clinical case
by: O.V. Onyshchenko, et al.
Published: (2023-12-01)